ALKS MEXC RealStocks
Own real ALKS shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-19 08:09:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Alkermes Inc. plc (ALKS) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $46.88, with a market capitalization of $7.64B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $27.00 to $55.67. This page covers its latest market performance, valuation, price trends and company information.
$7.64B | |
$45.26 | |
$47.07 | |
$45.26 | |
$45.45 | |
1.14M | |
1.90M | |
-- | |
$55.67 | |
$27.00 | |
-- | |
2026-09-30 |
Alkermes Inc. plc (ALKS) last closed at $46.88 as of 2026-11-19 00:55:00, up 3.10% ($1.41) from the previous close of $45.45.
During the latest regular trading session, ALKS traded between $45.26 and $47.07, with a volume of 1.14M shares. The closing price was near the upper end and near the upper end of its 52-week range.
Over the past seven days, Alkermes Inc. plc (ALKS) moved from $46.47 to $46.88, representing a gain of 0.87% ($0.41).
The stock traded between $45.10 and $48.30 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.
The average daily volume was 1.43 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 69.3%
ALKS is currently trading at $46.88, placing it 69.3% of the way from its 52-week low of $27.00 to its 52-week high of $55.67. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 2,050 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Alkermes Inc. plc (ALKS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to ALKS, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between ALKS shares and USD.
ALKS Shares to USD
1.00 ALKS shares = 46.875 USD
Calculations are estimates based on the latest available price and are for reference only.